About Brilliant Blue Biosciences
A team of materials scientists and molecular biologists
Founded in 2019 as an academic spin-out, Brilliant Blue Biosciences now runs co-development programmes with pharma, biotech and academic partners.
Follow us on LinkedIn
Let's engineer the next delivery breakthrough together
We co-develop nanocarrier and biosensing programmes with pharma, biotech and academic groups — from target selection through scale-up.
ResearchersRequest a technical consultationTalk formulation, characterisation or assay design with one of our scientists.Industry partnersExplore co-developmentFeasibility studies, co-development programmes and licensing.InvestorsExplore the market opportunitySourced market sizes, pipeline, investment and deal data for genetic medicine delivery.
